Stevens–Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People’s Republic of China

References

• Lee HY Chung WH Toxic epidermal necrolysis: the year in review Curr Opin Allergy Clin Immunol 2013 13 4 330 336 23799330
   PubMed Web of Science ®Google Scholar
• Naveen KN Pai VV Rai V Athanikar SB Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India Indian J Pharmacol 2013 45 1 80 82 23543919
   PubMed Web of Science ®Google Scholar
• Downey A Jackson C Harun N Cooper A Toxic epidermal necrolysis: review of pathogenesis and management J Am Acad Dermatol 2012 66 6 995 1003 22169256
   PubMed Web of Science ®Google Scholar
• Gerull R Nelle M Schaible T Toxic epidermal necrolysis and Stevens–Johnson syndrome: a review Crit Care Med 2011 39 6 1521 1532 21358399
   PubMed Web of Science ®Google Scholar
• Chan HL Stern RS Arndt KA The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients Arch Dermatol 1990 126 1 43 47 2404462
   PubMedGoogle Scholar
• Mittmann N Knowles SR Gomez M Fish JS Cartotto R Shear NH Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis Drug Saf 2004 27 7 477 487 15141997
   PubMed Web of Science ®Google Scholar
• Schwartz RA McDonough PH Lee BW Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis J Am Acad Dermatol 2013 69 2 173.e1 e13 quiz 185 23866878
   PubMed Web of Science ®Google Scholar
• Lissia M Mulas P Bulla A Rubino C Toxic epidermal necrolysis (Lyell’s disease) Burns 2010 36 2 152 163 19766401
   PubMed Web of Science ®Google Scholar
• Nassif A Bensussan A Boumsell L Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells J Allergy Clin Immunol 2004 114 5 1209 1215 15536433
   PubMed Web of Science ®Google Scholar
• Nassif A Bensussan A Dorothée G Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis J Invest Dermatol 2002 118 4 728 733 11918724
   PubMed Web of Science ®Google Scholar
• Paquet P Piérard GE Quatresooz P Novel treatments for drug-induced toxic epidermal necrolysis (Lyell’s syndrome) Int Arch Allergy Immunol 2005 136 3 205 216 15713983
   PubMed Web of Science ®Google Scholar
• Viard I Wehrli P Bullani R Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 1998 282 5388 490 493 9774279
   PubMed Web of Science ®Google Scholar
• Yamane Y Aihara M Ikezawa Z Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006 Allergol Int 2007 56 4 419 425 17713361
   PubMedGoogle Scholar
• Chen J Wang B Zeng Y Xu H High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases Eur J Dermatol 2010 20 6 743 747 20952352
   PubMed Web of Science ®Google Scholar
• Kamaliah MD Zainal D Mokhtar N Nazmi N Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia Int J Dermatol 1998 37 7 520 523 9679693
   PubMed Web of Science ®Google Scholar
• Bastuji-Garin S Fouchard N Bertocchi M Roujeau JC Revuz J Wolkenstein P SCORTEN: a severity-of-illness score for toxic epidermal necrolysis J Invest Dermatol 2000 115 2 149 153 10951229
   PubMed Web of Science ®Google Scholar
• Rajaratnam R Mann C Balasubramaniam P Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre Clin Exp Dermatol 2010 35 8 853 862 20456393
   PubMed Web of Science ®Google Scholar
• Barvaliya M Sanmukhani J Patel T Paliwal N Shah H Tripathi C Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study J Postgrad Med 2011 57 2 115 119 21654132
   PubMed Web of Science ®Google Scholar
• Lyell A Toxic epidermal necrolysis: an eruption resembling scalding of the skin Br J Dermatol 1956 68 11 355 361 13374196
   PubMed Web of Science ®Google Scholar
• Bastuji-Garin S Rzany B Stern RS Shear NH Naldi L Roujeau JC Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 1993 129 1 92 96 8420497
   PubMedGoogle Scholar
• Sharma VK Sethuraman G Adverse cutaneous reactions to drugs: an overview J Postgrad Med 1996 42 1 15 22 9715291
   PubMedGoogle Scholar
• Mockenhaupt M Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy J Dtsch Dermatol Ges 2009 7 2 142 60 quiz 161 19371237
   PubMed Web of Science ®Google Scholar
• Wolf R Lipozencic J Shape and configuration of skin lesions: targetoid lesions Clin Dermatol 2011 29 5 504 508 21855725
   PubMed Web of Science ®Google Scholar
• Roujeau JC The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification J Invest Dermatol 1994 102 6 28S 30S 8006430
   PubMed Web of Science ®Google Scholar
• Thammakumpee J Yongsiri S Characteristics of toxic epidermal necrolysis and Stevens-Johnson syndrome: a 5-year retrospective study J Med Assoc Thai 2013 96 4 399 406 23691693
   PubMedGoogle Scholar
• Jagadeesan S Sobhanakumari K Sadanandan SM Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: a prospective comparative open-labelled study of 36 cases Indian J Dermatol Venereol Leprol 2013 79 4 506 511 23760320
   PubMed Web of Science ®Google Scholar
• Kardaun SH Jonkman MF Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Acta Derm Venereol 2007 87 2 144 148 17340021
   PubMed Web of Science ®Google Scholar
• Kim PS Goldfarb IW Gaisford JC Slater H Stevens-Johnson syndrome and toxic epidermal necrolysis: a pathophysiologic review with recommendations for a treatment protocol J Burn Care Rehabil 1983 4 2 91 100
   Google Scholar
• Halebian PH Corder VJ Madden MR Finklestein JL Shires GT Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids Ann Surg 1986 204 5 503 512 3767483
   PubMed Web of Science ®Google Scholar
• Murphy JT Purdue GF Hunt JL Toxic epidermal necrolysis J Burn Care Rehabil 1997 18 5 417 420 9313122
   PubMedGoogle Scholar
• Lee HY Dunant A Sekula P The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies Br J Dermatol 2012 167 3 555 562 22639874
   PubMed Web of Science ®Google Scholar
• Bachot N Revuz J Roujeau JC Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression Arch Dermatol 2003 139 1 33 36 12533161
   PubMedGoogle Scholar
• Brown KM Silver GM Halerz M Walaszek P Sandroni A Gamelli RL Toxic epidermal necrolysis: does immunoglobulin make a difference? J Burn Care Rehabil 2004 25 1 81 88 14726744
   PubMedGoogle Scholar
• Metry DW Jung P Levy ML Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature Pediatrics 2003 112 6 Pt 1 1430 1436 14654625
   PubMed Web of Science ®Google Scholar
• Tristani-Firouzi P Petersen MJ Saffle JR Morris SE Zone JJ Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children J Am Acad Dermatol 2002 47 4 548 552 12271299
   PubMed Web of Science ®Google Scholar
• Aires DJ Fraga G Korentager R Early treatment with non-sucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality J Drugs Dermatol 2013 12 6 679 684 23839186
   PubMed Web of Science ®Google Scholar
• Trent JT Kirsner RS Romanelli P Kerdel FA Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience Arch Dermatol 2003 139 1 39 43 12533162
   PubMedGoogle Scholar
• Tripathi A Ditto AM Grammer LC Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases Allergy Asthma Proc 2000 21 2 101 105 10791111
   PubMed Web of Science ®Google Scholar
• Tan SK Tay YK Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes Acta Derm Venereol 2012 92 1 62 66 21710108
   PubMed Web of Science ®Google Scholar